Rare Diseases
Editorial
President's Message
EMWA News
Feature Articles
Essential investments in optimising clinical research for rare disease
Medical Writing. 2025;34(1):16–20
How can real-world data, registries, and databases address the challenges of rare diseases?
Medical Writing. 2025;34(1):46–50
Innovative use of master protocols for pivotal studies in rare diseases
Medical Writing. 2025;34(1):32–34
Living with a rare disease: A personal perspective
Medical Writing. 2025;34(1):12–15
Model-informed drug development in rare diseases
Medical Writing. 2025;34(1):36–39
Penning hope: The impact of medical writing for rare conditions
Medical Writing. 2025;34(1):52–54
Population diversity in clinical trials for rare diseases: A regulatory writer’s perspective
Medical Writing. 2025;34(1):42–45
Regulatory writing for rare disease: An interview with Kelley Hill
Medical Writing. 2025;34(1):22–21
Writing for orphan drugs: A compass to navigate document types and regional requirements
Medical Writing. 2025;34(1):24–30
Regular Sections
Good Writing Practice
Medical Writing. 2025;34(1):77
My First Medical Writing
Medical Writing. 2025;34(1):74–75
The Crofter: Sustainable Communications
Medical Writing. 2025;34(1):80–81